- Researchers have developed a new class of peptides that could provide the benefits of gastric bypass surgery without the need for invasive procedures.
- According to new research, these peptides contributed to significant weight loss and reduced blood glucose levels in rat models of obesity.
- The injectable compounds avoid the side effects of nausea and vomiting commonly experienced with current weight loss and diabetes drugs, and reduce eating while also increasing calorie burn.
Obesity and diabetes are serious public health concerns, and the former is one of the top risk factors for diabetes.
However, these procedures come with potential hazards, are not suitable for everyone, and are not readily available to most people.
Now, some researchers suggest that another treatment option could be to address metabolic issues through medication that emulates the long-term advantages of surgery.
After undergoing gastric bypass surgery, some people experience certain health benefits that are associated with changes in hormone secretion by the gut.
The hormones involved, including glucagon-like peptide-1 (GLP-1) and
Researchers have developed drugs that aim to replicate these effects by targeting GLP-1 receptors in the pancreas and brain.
These drugs have shown success in reducing weight and treating type 2 diabetes. Unfortunately, some people are unable to tolerate the side effects of these drugs, and
A team led by researchers from Syracuse University, NY, has developed a new peptide with the aim of addressing this need. They presented their recent research at…
Read the full article here